April19 Discovery
We use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegeneration and neural injuries, increasing brain longevity and extending human mental healthspan.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
35
organic / mo
Sign up free to see all 1 verified contacts at April19 Discovery
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at April19 Discovery
1 distinct titles indexed · top 1 shown.
- 1internship in drug discovery
Sign up to unlock all 1 contacts at April19 Discovery
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at April19 Discovery
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.